Bavarian Growth Fund
1
2M
1
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline Lophius Biosciences Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology.
The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2017. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Bavarian Growth Fund, startups are often financed by VRD GmbH, wolf biotech gmbh, WIC. The meaningful sponsors for the fund in investment in the same round are wolf biotech gmbh, VRD GmbH, Bayern Kapital GmbH.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Biotechnology (1)
- Health Diagnostics (1)
- Health Care (1)
- Investments by region
-
- Germany (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.